BPO 0.00% 0.3¢ bioprospect limited

now what?, page-5

  1. 3,230 Posts.
    Mr Pellegrino said the company anticipated achieving the registration of end-user products
    with the APVMA within the next two years, due to the need for additional data from field
    trials and the expected time required to achieve regulatory approval.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.